Martingale Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,307
Closed -$348K 830
2021
Q1
$348K Sell
5,307
-3,100
-37% -$191K ﹤0.01% 711
2020
Q4
$469K Sell
8,407
-22,900
-73% -$990K 0.01% 632
2020
Q3
$1.25M Sell
31,307
-37,200
-54% -$1.58M 0.02% 568
2020
Q2
$3.08M Hold
68,507
0.04% 418
2020
Q1
$2.3M Sell
68,507
-23,800
-26% -$856K 0.03% 456
2019
Q4
$3M Sell
92,307
-84,807
-48% -$2.41M 0.03% 497
2019
Q3
$4.42M Buy
177,114
+45,100
+34% +$1.29M 0.05% 412
2019
Q2
$3.94M Buy
132,014
+35,403
+37% +$1.03M 0.04% 433
2019
Q1
$2.59M Buy
96,611
+85,308
+755% +$2.59M 0.03% 537
2018
Q4
$347K Buy
+11,303
New +$352K ﹤0.01% 904

Other funds holding ATRC

Martingale Asset Management's ATRC Position: Q2 2021 in Review

Martingale Asset Management sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 5,307 shares — an estimated $348K sold.

Martingale Asset Management first reported a position in ATRC in Q4 2018 and held it in 10 quarters. The position peaked at $4.42M in Q3 2019. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

  • Martingale Asset Management reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
  • Martingale Asset Management sold 5,307 AtriCure shares in Q2 2021, an estimated $348K.
  • Martingale Asset Management first reported a position in AtriCure in Q4 2018 and held it in 10 quarters.
  • Martingale Asset Management's AtriCure position peaked at $4.42M in Q3 2019.
  • 212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Martingale Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.